top of page
Woman looking through microscope

What is 


Question mark

KRAS is the most common biomarker associated with lung, colorectal, pancreatic plus other cancers. Identified 50 years ago, researchers have learned that different sub-types of KRAS respond to treatments differently.  

We founded KRAS Kickers to actively monitor and share KRAS-related research developments, information and clinical trials within the community that will benefit the most, us.  We are the patients that need the best outcomes to live our lives.  

A biomarker is something measured by your doctor.  This helps to identify the best treatment options for your cancer.  KRAS targeted therapies are becoming options. 

Watch Terri's interview with Dr. David Carbone to learn more:

Dr. David Carbone is a professor of internal medicine, director of the James Thoracic Center at The Ohio State University Comprehensive Cancer Center, and holds the Barbara J. Bonner Chair in Lung Research. His research interests have been focused on lung cancer, lung cancer genetics, cancer immunotherapy, and tumor-associated immunosuppression mechanisms.

Want to watch more videos with Dr. Carbone?

See below!

  • How common is KRAS?
    KRAS is found in about 25% of lung cancer patients. This makes it one of the most common biomarkers.
  • How do I find out if I have KRAS?
    In order to find out if you have KRAS (pronounced KAY-ras), you need to do comprehensive biomarker testing. Only your doctor can order a test for you.
  • What is a biomarker?
    A biomarker is a way to tell what kind of mutation is driving the cancer in a patient. When a doctor understands the cancer’s composition, they can help tailor your treatment to your specific composition.
  • How do I know if I’ve had a biomarker test done?
    You can ask your doctor.
  • How do I get the results of my biomarker test?
    The results will be sent to your doctor and your doctor will interpret the test results for you.
  • I feel so overwhelmed. Is there a document that tells me what the standard of care is?
    The National Comprehensive Cancer Network (NCCN) is an alliance of 28 leading cancer centers. Their doctors have developed patient guidelines based on the latest research. These documents outline the basics of lung cancer, treatment options, and how to make treatment decisions. Here’s the NCCN Patient’s Guide (early stage) Here’s the NCCN Patient’s Guide (metastatic stage)
  • How do I connect with others who have KRAS?
    KRAS Kickers is here to help you connect with others. We offer support to patients and their loved ones. We also have a private support group on Facebook. We also have regular events, including networking events, zoom meetings with prominent KRAS oncologists, and conferences.

More Videos with Dr. David Carbone:

bottom of page